Apogee Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Henderson Jane | Chief Financial Officer | Sale | 1,500 | $80.00 | $120,000 | 193,371 | Dec 19, 2025 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sale | 560 | $76.58 | $42,885 | 1,212,987 | Dec 10, 2025 |
| Dambkowski Carl | Chief Medical Officer | Sale | 10,900 | $75.00 | $817,500 | 271,108 | Dec 4, 2025 |
| Henderson Jane | Chief Financial Officer | Sale | 1,500 | $75.00 | $112,500 | 194,871 | Dec 4, 2025 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sale | 40,000 | $75.01 | $3,000,400 | 1,232,987 | Dec 4, 2025 |
| Henderson Jane | Chief Financial Officer | Sale | 1,500 | $70.00 | $105,000 | 196,371 | Nov 25, 2025 |
| Henderson Jane | Chief Financial Officer | Sale | 2,000 | $65.00 | $130,000 | 197,871 | Nov 14, 2025 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sale | 100 | $64.52 | $6,452 | 1,272,987 | Nov 13, 2025 |
| Henderson Jane | Chief Financial Officer | Sale | 1,000 | $60.00 | $60,000 | 199,871 | Nov 11, 2025 |
| Dambkowski Carl | Chief Medical Officer | Sale | 678 | $56.51 | $38,314 | 282,008 | Nov 5, 2025 |
| Dambkowski Carl | Chief Medical Officer | Option Exercise | 2,385 | $22.86 | $54,521 | 289,843 | Oct 1, 2025 |
| Dambkowski Carl | Chief Medical Officer | Sale | 2,535 | $37.82 | $95,874 | 233,738 | Sep 3, 2025 |
| Dambkowski Carl | Chief Medical Officer | Sale | 2,725 | $37.78 | $102,951 | 236,273 | Aug 6, 2025 |
| Dambkowski Carl | Chief Medical Officer | Sale | 746 | $46.26 | $34,510 | 238,998 | Jul 2, 2025 |
| Dambkowski Carl | Chief Medical Officer | Sale | 2,725 | $36.96 | $100,716 | 241,723 | Jun 4, 2025 |
| Dambkowski Carl | Chief Medical Officer | Sale | 2,725 | $35.75 | $97,419 | 244,448 | May 7, 2025 |
| Dambkowski Carl | Chief Medical Officer | Sale | 500 | $37.03 | $18,515 | 248,062 | Apr 2, 2025 |
| Dambkowski Carl | Chief Medical Officer | Sale | 1,590 | $30.48 | $48,463 | 251,033 | Mar 5, 2025 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sale | 7,326 | $29.98 | $219,633 | 1,295,661 | Mar 5, 2025 |
| Dambkowski Carl | Chief Medical Officer | Option Exercise | 795 | $22.86 | $18,174 | 256,143 | Feb 5, 2025 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sale | 15,000 | $40.58 | $608,700 | 1,302,987 | Feb 5, 2025 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Option Exercise | 8,500 | $22.86 | $194,310 | 1,317,987 | Jan 31, 2025 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sale | 2,868 | $49.38 | $141,622 | 1,309,487 | Jan 8, 2025 |
| Dambkowski Carl | Chief Medical Officer | Sale | 2,486 | $47.21 | $117,364 | 255,448 | Jan 2, 2025 |
| McKenna Mark C. | — | Purchase | 7,500 | $49.02 | $367,650 | 7,500 | Dec 12, 2024 |
| Dambkowski Carl | Chief Medical Officer | Option Exercise | 1,815 | $22.86 | $41,491 | 262,613 | Dec 11, 2024 |
| Dambkowski Carl | Chief Medical Officer | Sale | 6,665 | $46.07 | $307,057 | 260,798 | Dec 4, 2024 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sale | 13,328 | $46.50 | $619,752 | 1,326,159 | Dec 4, 2024 |
| Dambkowski Carl | Chief Medical Officer | Sale | 1,339 | $59.96 | $80,286 | 267,463 | Nov 6, 2024 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sale | 1,000 | $59.94 | $59,940 | 1,339,487 | Nov 6, 2024 |
| Dambkowski Carl | Chief Medical Officer | Sale | 925 | $56.86 | $52,596 | 274,128 | Oct 2, 2024 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sale | 9,712 | $56.74 | $551,059 | 1,354,487 | Oct 2, 2024 |
| Dambkowski Carl | Chief Medical Officer | Sale | 787 | $48.06 | $37,823 | 280,793 | Sep 4, 2024 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sale | 14,359 | $48.23 | $692,535 | 1,394,487 | Sep 4, 2024 |
| Henderson Jane | Chief Financial Officer | Sale | 6,000 | $48.26 | $289,560 | 200,871 | Aug 23, 2024 |
| Dambkowski Carl | Chief Medical Officer | Sale | 142 | $41.09 | $5,835 | 288,128 | Aug 7, 2024 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sale | 32,233 | $40.40 | $1,302,213 | 1,442,254 | Aug 7, 2024 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sale | 15,000 | $37.26 | $558,900 | 1,474,487 | Jul 5, 2024 |
| Dambkowski Carl | Chief Medical Officer | Sale | 3,852 | $37.29 | $143,641 | 296,936 | Jul 3, 2024 |
| Harwin Peter Evan | — | Other | 55,913 | — | — | 2,048,647 | Mar 28, 2024 |
| Harwin Peter Evan | — | Other | 51,166 | — | — | 51,166 | Jan 29, 2024 |
| Shah Nimish P | — | Purchase | 1,750,000 | $17.00 | $29,750,000 | 1,750,000 | Jul 13, 2023 |
| Fairmount Funds Management LLC | — | Purchase | 892,529 | $17.00 | $15,172,993 | 892,529 | Jul 13, 2023 |